CYP enzyme polymorphisms and susceptibility to HCV-related chronic liver disease and liver cancer

This publication has 52 references indexed in Scilit:

• Increased risk for hepatocellular carcinoma in NAT2-slow acetylators and CYP2D6-rapid metabolizers
  Pharmacogenetics, 1996
• Role of CYP2E1 in the Hepatotoxicity of Acetaminophen
  Journal of Biological Chemistry, 1996
• CYP2D6 genes and risk of liver cancer
  The Lancet, 1995
• Mechanisms of cell injury by activated oxygen species.
  Environmental Health Perspectives, 1994
• Hepatocellular carcinoma
  Journal of Hepatology, 1992
• The Human Hepatic Cytochromes P450 Involved in Drug Metabolism
  Critical Reviews in Toxicology, 1992
• Concordance of P450 2D6 (debrisoquine hydroxylase) phenotype and genotype
  Pharmacogenetics, 1991
• Identification of genetically high risk individuals to lung cancer by DNA polymorphisms of the cytochrome P45 0IA1 gene
  FEBS Letters, 1990
• SIMCA: A Program to Perform Simple Correspondence Analysis
  The American Statistician, 1986
• Genetically determined debrisoquine oxidation capacity in bladder cancer
  Carcinogenesis: Integrative Cancer Research, 1984